These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 30576500)

  • 21. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.
    Gao H; Meng J; Xing H; Nie S; Xu M; Zhang S; Jin Y; Sun T; Huang H; Zhang H; Wang D; Liu L
    Hum Reprod; 2014 May; 29(5):1058-66. PubMed ID: 24585089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.
    Brower MA; Hai Y; Jones MR; Guo X; Chen YI; Rotter JI; Krauss RM; Legro RS; Azziz R; Goodarzi MO
    Hum Reprod; 2019 Jan; 34(1):127-136. PubMed ID: 30496407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis.
    Dobbie LJ; Pittam B; Zhao SS; Alam U; Hydes TJ; Barber TM; Cuthbertson DJ
    Hum Reprod; 2023 Jun; 38(6):1168-1182. PubMed ID: 37015099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles.
    Willis GR; Connolly K; Ladell K; Davies TS; Guschina IA; Ramji D; Miners K; Price DA; Clayton A; James PE; Rees DA
    Hum Reprod; 2014 Dec; 29(12):2756-63. PubMed ID: 25336711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome.
    Harnois-Leblanc S; Trottier A; Leblanc S; Battista MC; Geller DH; Baillargeon JP
    Reprod Biol Endocrinol; 2017 Jul; 15(1):56. PubMed ID: 28738839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
    Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
    Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.
    González F; Sia CL; Shepard MK; Rote NS; Minium J
    Hum Reprod; 2012 Dec; 27(12):3560-8. PubMed ID: 22940766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
    Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
    Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
    Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
    de Wilde MA; Goverde AJ; Veltman-Verhulst SM; Eijkemans MJ; Franx A; Fauser BC; Koster MP
    Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.
    Fusco A; Bianchi A; Mancini A; Milardi D; Giampietro A; Cimino V; Porcelli T; Romualdi D; Guido M; Lanzone A; Pontecorvi A; De Marinis L
    J Endocrinol Invest; 2007 Dec; 30(11):948-56. PubMed ID: 18250617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
    Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ
    Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.